Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes.
about
Autoantibodies and liver disease: uses and abuses.Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence testsMicrobead-based technologies in diagnostic autoantibody detection.Antibody biomarker discovery through in vitro directed evolution of consensus recognition epitopesStaining pattern classification of antinuclear autoantibodies based on block segmentation in indirect immunofluorescence images.New platform technology for comprehensive serological diagnostics of autoimmune diseasesCirculating Natural IgM Antibodies Against Angiogenin in the Peripheral Blood Sera of Patients with Osteosarcoma as Candidate Biomarkers and Reporters of TumorigenesisOriginal approach for automated quantification of antinuclear autoantibodies by indirect immunofluorescence.Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease.The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease.Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist.EUROPattern Suite technology for computer-aided immunofluorescence microscopy in autoantibody diagnostics.Anti-cardiac troponin antibodies in clinical human disease: a systematic review.Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.Diagnostic profile on the IFA 40: HEp-20-10 - an immunofluorescence test for reliable antinuclear antibody screening.The burden of the variability introduced by the HEp-2 assay kit and the CAD system in ANA indirect immunofluorescence test.Anti-Mitotic Spindle Apparatus Antoantibodies: Prevalence and Disease Association in Chinese Population.The Reliability of a Novel Automated System for ANA Immunofluorescence Analysis in Daily Clinical PracticeEvaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases.A novel automated indirect immunofluorescence autoantibody evaluation.Rheumatic Disease Autoantibodies in Autoimmune Liver Diseases.Microarray technology displays the complexities of the humoral immune response.
P2860
Q33829963-54A4B714-C204-4ECF-8FCD-87710578F34CQ33923278-D357A331-2BAB-4547-92C8-0D4E9EA22F5FQ34621309-8CC91D6C-A8A6-45CB-8983-200428B44562Q35039983-AD1C3097-1C76-4417-83B2-57015E119EE8Q35488962-A57B7991-0661-42F5-A7A7-C5753F6566B1Q36505735-0987BFAC-97E1-4982-82D0-FBD8170F7F8CQ37198133-64AB2F40-0A95-4439-9DAF-129293EAC695Q37425948-6E6ED7BD-1691-47DA-AAD8-9673743E3E61Q37552017-FE30960B-E9CF-46FC-8664-8DA373335AEBQ37674765-F323CD54-1949-4325-B3BD-72C7DD8A8896Q37824303-EE62C42E-E8F6-4C12-BC43-47CE26727F31Q37826112-AF819081-A8F2-43B1-81BD-68E6289EA04DQ37826114-D2AEEA79-A32D-4D88-A60C-C8004E568367Q38100736-0B021979-9D37-4121-ADE5-A06A96950153Q38388432-9C33C30F-42FD-4507-8DBA-F713748C51DAQ38601283-2FC0A17D-CE69-424F-A68F-213CD98BCEB0Q38883608-21EAE354-530D-479D-B236-B5083FFE24F1Q38926484-A3C8EE74-3F2D-473B-9D99-B42F3166BD82Q39561761-C9FD461D-4024-497A-9071-2B7AE5DC0649Q39912120-94BA36A5-0AF8-4CFB-8872-50138B0AA66AQ42252941-83DF4390-5677-4CF8-AB20-778E539A283BQ46669235-42928683-D72A-4934-A84B-58554669F5DEQ51504100-5C327AF4-EAD2-48F0-B91F-F9490D78428EQ51645021-BD7AC1AF-5AEC-476E-B381-38588463DDDDQ53995676-B04706C3-FEDF-4122-9018-6DCF2D4824DE
P2860
Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Challenges to the use of autoa ...... onset, diagnosis and outcomes.
@en
Challenges to the use of autoa ...... onset, diagnosis and outcomes.
@nl
type
label
Challenges to the use of autoa ...... onset, diagnosis and outcomes.
@en
Challenges to the use of autoa ...... onset, diagnosis and outcomes.
@nl
prefLabel
Challenges to the use of autoa ...... onset, diagnosis and outcomes.
@en
Challenges to the use of autoa ...... onset, diagnosis and outcomes.
@nl
P1433
P1476
Challenges to the use of autoa ...... onset, diagnosis and outcomes.
@en
P304
P356
10.1016/J.AUTREV.2008.06.007
P577
2008-07-09T00:00:00Z